 |
|
Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
Byung Woo Jhun, Won-Jung Koh
Tuberc Respir Dis. 2020;83(1):20-30. Published online 2019 Nov 7 DOI: https://doi.org/10.4046/trd.2019.0065
|
|
Citations to this article as recorded by
 Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
Dana J. Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2024; 44(3): 268. CrossRef Synthesis and Anti-Mycobacterium Activity of Some New N-Rich Heterocyclic Derivatives and Their Molecular Docking, and DFT Studies
Raghavendra Hegde, Itte Pushpavathi, Talavara Venkatesh, O. Nagaraja, S. Ravi Kumar
Russian Journal of Bioorganic Chemistry.2024; 50(1): 147. CrossRef Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis
Zitong Shao, Kingsley King-Gee Tam, V.P.K. Achalla, Esther C.Y. Woon, A. James Mason, Shing Fung Chow, Wing Cheong Yam, Jenny K.W. Lam
International Journal of Pharmaceutics.2024; 654: 123960. CrossRef Performance of the BD MAX MDR-TB assay in a clinical setting and its impact on the clinical course of patients with pulmonary tuberculosis: a retrospective before-after study
Sung Jun Ko, Kui Hyun Yoon, Sang Hee Lee
Journal of Yeungnam Medical Science.2024; 41(2): 113. CrossRef Amino-functionalised mesoporous silica nanoparticles for the delivery of isoniazid and its metal complexes
Josephine Oluwagbemisola Tella, Joseph Adeyemi Adekoya, Kolawole Oluseyi Ajanaku, Rajkumar Banerjee, Chitta Ranjan Patra, Srinivasu Pavuluri, Bojja Sreedhar
Materials Chemistry and Physics.2024; 326: 129820. CrossRef Clinical Profile and Treatment Outcome of H-mono/Polydrug-resistant Tuberculosis: A Single-center Retrospective Study
Shital Kabra, Snehal Jadhav
Journal of Advanced Lung Health.2024;[Epub] CrossRef Benzenesulfonohydrazide-tethered non-fused and fused heterocycles as potential anti-mycobacterial agents targeting enoyl acyl carrier protein reductase (InhA) with antibiofilm activity
Tarfah Al-Warhi, Ahmed Sabt, Małgorzata Korycka-Machala, Asmaa F. Kassem, Moataz A. Shaldam, Hoda Atef Abdelsattar Ibrahim, Malwina Kawka, Bożena Dziadek, Magdalena Kuzioła, Wagdy M. Eldehna, Jarosław Dziadek
RSC Advances.2024; 14(41): 30165. CrossRef The Hidden Epidemic of Isoniazid-Resistant Tuberculosis in South Africa
Marisa Klopper, Charnay J. van der Merwe, Yuri F. van der Heijden, Megan Folkerts, Johannes Loubser, Elizabeth M. Streicher, Kate Mekler, Cindy Hayes, David M. Engelthaler, John Z. Metcalfe, Robin M. Warren
Annals of the American Thoracic Society.2024; 21(10): 1391. CrossRef Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: an exploratory study
S. M. Mazidur Rahman, Pushpita Samina, Tanjina Rahman, Ahammad Shafiq Sikder Adel, Rumana Nasrin, Mohammad Khaja Mafij Uddin, Md Jahid Hasan, Shahriar Ahmed, Paul Daru, Pronab Kumar Modak, Md Abdul Hamid Salim, Sardar Munim Ibna Mohsin, Sayera Banu
Clinical Microbiology and Infection.2024;[Epub] CrossRef An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management
Hitesh Chopra, Yugal Kishore Mohanta, Pradipta Ranjan Rauta, Ramzan Ahmed, Saurov Mahanta, Piyush Kumar Mishra, Paramjot Panda, Ali A. Rabaan, Ahmad A. Alshehri, Basim Othman, Mohammed Abdulrahman Alshahrani, Ali S. Alqahtani, Baneen Ali AL Basha, Kuldeep
Pharmaceuticals.2023; 16(4): 581. CrossRef Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review
Leeberk Raja Inbaraj, Hemant Deepak Shewade, Jefferson Daniel, Vignes Anand Srinivasalu, Jabez Paul, S. Satish, Richard Kirubakaran, Chandrasekaran Padmapriyadarsini
Frontiers in Medicine.2023;[Epub] CrossRef Human Serum Albumin Nanoparticles: Synthesis, Optimization and Immobilization with Antituberculosis Drugs
Aldana Galiyeva, Arailym Daribay, Tolkyn Zhumagaliyeva, Lyazzat Zhaparova, Daniyar Sadyrbekov, Yerkeblan Tazhbayev
Polymers.2023; 15(13): 2774. CrossRef Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study
Ali A. Rabaan, Muhammad A. Halwani, Mohammed Garout, Safaa A. Turkistani, Roua A. Alsubki, Abdulsalam Alawfi, Amer Alshengeti, Mustafa A. Najim, Nawal A. Al Kaabi, Thikrayat Q. Alqazih, Ali A. Aseeri, Afnan S. Bahitham, Manal A. Alsubaie, Mohammed Alissa,
Molecular Diversity.2023;[Epub] CrossRef Factors influencing the initiation and adherence of LTBI treatment in healthcare workers: a systematic review
Hyunju Yang, Hyunyoung Park
Archives of Environmental & Occupational Health.2022; 77(1): 76. CrossRef Highly sensitive and selective voltammetric detection of isoniazid drug based on graphene oxide‐gold nanourchin‐poly(aniline) nanocomposite
Zahra Zareie, Navid Nasirizadeh, Mohammad Mirjalili, Masoud Rohani-moghadam, Mohammadali Shirgholami
Measurement.2022; 189: 110431. CrossRef Time for Isoniazid Pharmacogenomic-Guided Therapy of Tuberculosis Based on NAT2 Acetylation Profiles in India
Nikhat Khan, Aparup Das
European Journal of Drug Metabolism and Pharmacokinetics.2022; 47(4): 443. CrossRef Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis
Wenbin Kuang, Haolin Zhang, Xiao Wang, Peng Yang
Acta Pharmaceutica Sinica B.2022; 12(8): 3201. CrossRef Very-Rapidly Dissolving Printlets of Isoniazid Manufactured by SLS 3D Printing: In Vitro and In Vivo Characterization
Tahir Khuroo, Eman M. Mohamed, Sathish Dharani, Canberk Kayalar, Tanil Ozkan, Mathew A. Kuttolamadom, Ziyaur Rahman, Mansoor A. Khan
Molecular Pharmaceutics.2022; 19(8): 2937. CrossRef Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
Kamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, Richard Court, Xin Sun, Laura Moran, Richard Hafner, Lubbe Wiesner, Susan L Rosenkranz, Veronique de Jager, Nihal de Vries, Joseph Harding, Tawanda Gumbo, Susan Swindells, Andreas Diacon, Kelly E Dool
Journal of Antimicrobial Chemotherapy.2022; 77(9): 2489. CrossRef Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study
Jinsoo Min, Hyung Woo Kim, Ji Young Kang, Sung Kyoung Kim, Jin Woo Kim, Yong Hyun Kim, Hyoung Kyu Yoon, Sang Haak Lee, Ju Sang Kim, Vipa Thanachartwet
PLOS ONE.2022; 17(8): e0273263. CrossRef Fingerprinting of Mycobacterium tuberculosis isolates by MIRU-VNTR genotyping and detection of isoniazid resistance by real-time PCR
Ahmed Gaballah, Abeer Ghazal, Reda Almiry, Somaya Hussein, Rasha Emad, Eglal El-Sherbini
Journal of Medical Microbiology.2022;[Epub] CrossRef CURRENT APPROACHES TO CONTROL OF ISONIAZID-RESISTANT TUBERCULOSIS
Vladimir Milanov, Nikolay Yanev, Natalia Gabrovska, Denitsa Dimitrova, Elizabeta Bachiyska, Vania Youroukova
PROBLEMS of Infectious and Parasitic Diseases.2022; 50(1): 25. CrossRef Magnitude of Phenotypic and MTBDRplus Line Probe Assay First-Line Anti-Tuberculosis Drug Resistance Among Tuberculosis Patients; Northwest Ethiopia
Wubet Birhan Yigzaw, Jordi B Torrelles, Shu-Hua Wang, Belay Tessema
Infection and Drug Resistance.2021; Volume 14: 497. CrossRef The use of photogenerated iodine for the determination of isoniazid in solid dosage formulation
E. V. Turusova, O. E. Nasakin, A. N. Lyshchikov
Industrial laboratory. Diagnostics of materials.2021; 87(3): 5. CrossRef Molecular Detection of Drug-Resistant Mycobacterium tuberculosis in Sputum Specimens from the New and Previously Treated Tuberculosis Cases at the National Reference Chest Diseases Laboratory in Lusaka, Zambia
DK Mumena, G Kwenda , CW Ngugi , AK Nyerere
Journal of Biomedical Research & Environmental Sciences.2021; 2(4): 232. CrossRef Designing inhalable metal organic frameworks for pulmonary tuberculosis treatment and theragnosticsviaspray drying
Ignacio Luz, Ian E. Stewart, Ninell P. Mortensen, Anthony J. Hickey
Chemical Communications.2020; 56(87): 13339. CrossRef
|